Evidence map›Paper›PMID 32774775›Full record

ArticleOncotarget2020

Correction: SNiPER: a novel hypermethylation biomarker panel for liquid biopsy based early breast cancer detection.

Jolein Mijnes, Janina Tiedemann, Julian Eschenbruch, Janina Gasthaus, Sarah Bringezu, Dirk Bauerschlag, Nicolai Maass, Norbert Arnold, Jörg Weimer, Tobias Anzeneder and 12 more

Abstract readPublished Erratum
PubMed Full text at PMC Publisher
In one paragraph

Article in Oncotarget, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

22 authors.

Jolein MijnesMolecular Oncology Group, Institute of Pathology, University Hospital RWTH Aachen, Aachen, Germany.
Janina TiedemannMolecular Oncology Group, Institute of Pathology, University Hospital RWTH Aachen, Aachen, Germany.
Julian EschenbruchMolecular Oncology Group, Institute of Pathology, University Hospital RWTH Aachen, Aachen, Germany.
Janina GasthausMolecular Oncology Group, Institute of Pathology, University Hospital RWTH Aachen, Aachen, Germany.
Sarah BringezuMolecular Oncology Group, Institute of Pathology, University Hospital RWTH Aachen, Aachen, Germany.
Dirk BauerschlagDepartment of Gynecology and Obstetrics, University Medical Centre Schleswig-Holstein, Campus Kiel, Kiel, Germany.
Nicolai MaassDepartment of Gynecology and Obstetrics, University Medical Centre Schleswig-Holstein, Campus Kiel, Kiel, Germany.
Norbert ArnoldDepartment of Gynecology and Obstetrics, University Medical Centre Schleswig-Holstein, Campus Kiel, Kiel, Germany.
Jörg WeimerDepartment of Gynecology and Obstetrics, University Medical Centre Schleswig-Holstein, Campus Kiel, Kiel, Germany.
Tobias AnzenederPatients' Tumor Bank of Hope (PATH-Biobank) Foundation, München, Germany.
Peter A FaschingDepartment of Gynecology and Obstetrics, University Hospital Erlangen, Erlangen, Germany.
Matthias RübnerDepartment of Gynecology and Obstetrics, University Hospital Erlangen, Erlangen, Germany.
Benjamin BrunoDepartment of Gynecology and Obstetrics Luisenhospital, Aachen, Germany.
Uwe HeindrichsDepartment of Gynecology and Obstetrics Luisenhospital, Aachen, Germany.
Jennifer FreresDepartment of Gynecology and Obstetrics Luisenhospital, Aachen, Germany.
Hanna SchulzMolecular Oncology Group, Institute of Pathology, University Hospital RWTH Aachen, Aachen, Germany.
Ralf-Dieter HilgersInstitute of Medical Statistics, University Hospital RWTH Aachen, Aachen, Germany.
Nadina Ortiz-BrüchleMolecular Oncology Group, Institute of Pathology, University Hospital RWTH Aachen, Aachen, Germany.
Sonja von SerenyiMolecular Oncology Group, Institute of Pathology, University Hospital RWTH Aachen, Aachen, Germany.
Ruth KnüchelMolecular Oncology Group, Institute of Pathology, University Hospital RWTH Aachen, Aachen, Germany.
Vera KlotenMolecular Oncology Group, Institute of Pathology, University Hospital RWTH Aachen, Aachen, Germany.
Edgar DahlMolecular Oncology Group, Institute of Pathology, University Hospital RWTH Aachen, Aachen, Germany.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

[This corrects the article DOI: 10.18632/oncotarget.27303.].

Identifiers

PMID32774775
PMCPMC7392623

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.